Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message.

Source:http://linkedlifedata.com/resource/pubmed/id/11352964

J. Clin. Oncol. 2001 May 15 19 10 2714-21

Download in:

View as

General Info

PMID
11352964